Proteios Technology, Inc.
CAGE Code: 7FC04
NCAGE Code: 7FC04
Status: Active
Type: Commercial Supplier
Summary
Proteios Technology, Inc. is an Active Commercial Supplier with the Cage Code 7FC04.
Address
580 Wilderness Peak Dr Nw
Issaquah WA 98027-5621
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Lakeside Industries Mupro Inc Basker Computer Group Inc Thunderheart Llc Hodge Construction Inc Div Of Dayco Siemens Medical Systems Inc Herzog Bill Co Nissus Capital, Llc D Square Generator Service Miners And Pisani Inc Lakeside Industries Inc Northwest Reports Inc Lee Spring Co Futzer Avenue Consulting And Sales Issaquah Welding Supply Inc Evans Norman G Arbor Medical Inc Avantech Instruments C.A. Carey Corporation Northwest Motion Inc.
Frequently Asked Questions (FAQ) for CAGE 7FC04
- What is CAGE Code 7FC04?
- 7FC04 is the unique identifier used by NATO Organizations to reference the physical entity known as Proteios Technology, Inc. located at 580 Wilderness Peak Dr Nw, Issaquah WA 98027-5621, United States.
- Who is CAGE Code 7FC04?
- 7FC04 refers to Proteios Technology, Inc. located at 580 Wilderness Peak Dr Nw, Issaquah WA 98027-5621, United States.
- Where is CAGE Code 7FC04 Located?
- CAGE Code 7FC04 is located in Issaquah, WA, USA.
Contracting History for CAGE 7FC04 Most Recent 25 Records
- 75N91023C00028
- Sbir Phase Ii, Topic 429: A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing
- 13 Sep 2023
- Sbir Phase Ii, Topic 429: A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $2,049,979.00
- Department Of Health And Human Services (Hhs)
- 75N91021C00017
- Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 12, 2022 Fy21 Phase I Sbir
- 3 Sep 2021
- Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 12, 2022 Fy21 Phase I Sbir
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $400,000.00
- Department Of Health And Human Services (Hhs)
- 75N91021C00017
- Eo14042-Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 12, 2022 Fy21 Phase I Sbir
- 28 Oct 2021
- Eo14042-Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 12, 2022 Fy21 Phase I Sbir
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $400,000.00
- Department Of Health And Human Services (Hhs)
- 75N91021C00017
- Eo14042-Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 21, 2022 Fy21 Phase I Sbir
- 4 Apr 2022
- Eo14042-Topic 429 A New Paradigm For Autologous And Allogeneic Cell Therapy Manufacturing Period Of Performance September 13, 2021-June 21, 2022 Fy21 Phase I Sbir
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $455,000.00
- Department Of Health And Human Services (Hhs)